Featured Stories
Power Hour Surge: Cover Story, FDA Catalysts, Rare Earths, and a $7.8B Biotech Buyout
As the final hour of trading unfolds, momentum is clustering around breakthrough science, regulatory catalysts, strategic commodities, and headline M&A. Here are the stocks commanding attention into the close and potentially into afterhours.
Exposure Surge, Immunotherapy Expansion, and a $1.1B Healthcare Takeout
Midday trading is being shaped by a powerful mix of biotech momentum, breakthrough materials science, and strategic buyouts, as investors rotate toward companies delivering tangible catalysts.
Biotech & Obesity Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger
Wall Street opens to a convergence of science, scale, and strategic consolidation. From spider silk making mainstream headlines to multibillion-dollar oncology deals and accelerating immunotherapy revenues, today’s tape reflects capital flowing toward platforms with validation.
Kraig Biocraft Laboratories Featured on the Cover of National Geographic
Kraig Biocraft Laboratories (OTCQB: KBLB) groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine.
Latest
Feb 23, 2026, 4:03 PM
Feb 23, 2026, 4:01 PM
Feb 23, 2026, 3:59 PM
Feb 23, 2026, 6:04 AM
Feb 23, 2026, 5:24 AM
More News
Hormones, Homes, High-Performance Fibers and High-Density Compute
Feb 20, 2026, 8:47 PM
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform
Feb 20, 2026, 5:37 PM

